In order to better understand how innovation perspectives and actions are changing across Australian business leaders, as we adjust to a new post-COVID operating environment, KPMG’s Digital Delta Innovation Strategy team invites you to complete a short survey.
Innovation is at the heart of the life sciences sector and, more broadly, business leaders consistently indicate that it is amongst their top business priorities. The world has been disrupted, and this survey seeks to understand how capacity for innovation, the practices, and outcomes have changed as a result.
For the purposes of this exercise, KPMG is defining ‘innovation’ as any strategy or activity that seeks to create new ideas, products or solutions for your organisation.
Participants may choose to receive a copy of the survey report summarising the findings, which may guide your innovation efforts going forward.
The confidential survey will close on 17 July 2020.